Biohaven

About Biohaven Pharmaceutical

Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for neurological, immunological, and oncological diseases. With a diverse pipeline of product candidates in various stages of clinical development, Biohaven targets conditions such as epilepsy, migraine, Alzheimer's and Parkinson's diseases, rheumatoid arthritis, myasthenia gravis, IgA nephropathy, dilated cardiomyopathy, multiple myeloma, and Hodgkin's lymphoma. The company leverages proprietary drug development platforms and strategic collaborations to advance treatments for diseases with significant unmet medical needs. Biohaven is headquartered in New Haven, Connecticut, and serves patients worldwide.